The Latest Cardiac and Vascular News
Sweden–Gothenburg and Germany-Pforzheim, October 25, 2022 (https://news.cision.com/mentice-ab). GOTHENBURG, Sweden, Oct. 25, 2022 /PRNewswire/ — Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzheim, a leading innovator of minimal invasive devices for the treatment of neurovascular diseases, has signed a 3-year collaboration agreement to further develop the Acandis […]
STOCKHOLM, April 27, 2022 /PRNewswire/ — A strong start for the year with continued overall growth Our strong finish of 2021 is now followed by a first quarter of 2022 with considerable growth for both order intake and net sales. We increased the order book to 91.4 (72.9) MSEK compared to the end […]
Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China via an official importation agent, has placed an order of ten (10) Mentice VIST simulator packages including the Siemens Virtual Patient Link software to be bundled with the Corindus CorPath GRX Robitic system sales […]
STOCKHOLM, Feb. 3, 2022 /PRNewswire/ — Continued strength with net sales growth above 30% despite the pandemic Fourth quarter (October-December 2021) Order intake amounted to 73.7 (73.1) MSEK. Net sales amounted to 67.7 (45.9) MSEK. Operating income for the period before depreciations (EBITDA) totalled 12.0 (4.3) MSEK. Net income for the period amounted […]
STOCKHOLM, Oct. 18, 2021 /PRNewswire/ — Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has through its fully owned subsidiary Mentice Inc entered into an agreement with ABBOTT Inc. to provide simulation solutions for training of interventional devices. The order covers systems that will be offered […]
STOCKHOLM, April 28, 2021 /PRNewswire/ — Strongest order intake in Mentice’s history despite the corona pandemic First quarter (January-March 2021) Order intake amounted to 39.9 (32.5) MSEK. Order book by end of the period was 72.9 (33.9) MSEK. Net sales amounted to 32.3 (33.8) MSEK. Operating income for the period before depreciations (EBITDA) […]
STOCKHOLM, April 15, 2021 /PRNewswire/ — Mentice AB (STO: MNTC), a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, today announced the appointment of Pontus Appelqvist as Vice President and General Manager for Asia Pacific. Pontus has more than 20 years of enterprise leadership experience in driving new […]
GOTHENBURG, Sweden, July 1, 2020 /PRNewswire/ — Mentice AB (STO: MNTC) today announced the appointment of Thanos Karras as the company’s new General Manager for Americas. Thanos’ appointment will play a critical role in supporting Mentice’s continual growth strategy and will help accelerate its leadership position in high fidelity endovascular simulation solutions. Vice President […]
VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications GOTHENBURG, Sweden, May 19, 2020 /PRNewswire/ — Mentice AB (STO: MNTC), today announced the global introduction of its seventh-generation simulation platform – VIST® G7 to become the endovascular simulation platform for Mentice solutions including […]
STOCKHOLM, March 12, 2020 /PRNewswire/ — Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essentials three months earlier at the 20th International Meeting on Simulation in Healthcare […]
